Quantcast

4th Circuit revives Baltimore’s lawsuit against drug maker

A federal appeals court has revived Baltimore’s lawsuit to recover the hundreds of thousands of dollars the city claims to have overpaid for blood-pressure pills because the drug’s manufacturer illegally cornered the market. Baltimore claims Actelion Pharmaceuticals Ltd.’s failure to cooperate with would-be generic makers of its drug Tracleer violated federal antitrust law by blocking the ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.